PHASE 1 RANDOMIZED STUDY OF THE STEADY-STATE (SS) EFFECTS OF BEMPEDOIC ACID (BA) ON THE SINGLE-DOSE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC) TABLETS IN HEALTHY FEMALES.

被引：0
|
作者：
Emery, M. [1 ]
MacDougall, D. [1 ]
Amore, B. [1 ]
McGonigal, J. [1 ]
Hanselman, J. [1 ]
Sasiela, W. [1 ]
机构：
[1] Esper Therapeut, Ann Arbor, MI USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-002
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 46 条
  • [31] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ASCENDING SINGLE-DOSE, PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF AMG 529, A NOVEL ANTI-ASGR1 MONOCLONAL ANTIBODY, IN HEALTHY SUBJECTS
    Janiszewski, Mariano
    Sohn, Winnie
    Su, Cheng
    Hsu, Yi Hsiang
    Finger, Elizabeth
    Kaufman, Allegra
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1755 - 1755
  • [32] PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH EU-APPROVED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, TWO-ARM, SINGLE-DOSE STUDY IN HEALTHY SUBJECTS
    Yu, K. S.
    Kim, B.
    Shin, D.
    Park, M. K.
    Hwang, J. G.
    Kim, M.
    Chung, H.
    Ghim, J.
    Chung, J. Y.
    Smolen, J. S.
    Burmester, G. R.
    Kim, S. H.
    Bae, Y.
    Jeon, D.
    Yang, G.
    Yoo, J.
    Bae, J.
    Keystone, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1385 - 1386
  • [33] Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive-extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects
    Gordi, Toufigh
    Hou, Eddie
    Kasichayanula, Sreeneeranj
    Berner, Bret
    CLINICAL THERAPEUTICS, 2008, 30 (05) : 909 - 916
  • [34] A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects
    Garey, Kevin W.
    Begum, Khurshida
    Lancaster, Chris
    Gonzales-Luna, Anne
    Dinh Bui
    Mercier, Julie
    Yue, Corinne Seng
    Ducharme, Murray P.
    Hu, Ming
    Vince, Bradley
    Silverman, Michael H.
    Alam, M. Jahangir
    Kankam, Martin
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (12) : 3635 - 3643
  • [35] DB959-101: A Phase 1 Randomized, Placebo-Controlled, Double-Blind, Escalating Single-Dose Study To Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of DB959Na in Healthy Male and Female Volunteers
    Delmedico, Mary K.
    Wargin, William A.
    Schutz, Ralph A.
    Banks, Geoffrey C.
    Spruill, Susan E.
    Dalton, Michael J.
    Grossman, Steven H.
    DIABETES, 2011, 60 : A286 - A287
  • [36] PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSEDTOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH INTRAVENOUS EU-APPROVEDTOCILIZUMAB AND US-LICENSEDTOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND,THREE-ARM, SINGLE-DOSE STUDY IN HEALTHY JAPANESE SUBJECTS
    Haranaka, M.
    Eto, T.
    Tanaka, T.
    Yazawa, R.
    Burmester, G. R.
    Keystone, E.
    Kim, S. H.
    Bae, Y.
    Suh, J.
    Kim, Y.
    Lee, J.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [37] Pharmacokinetics of Co-Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed-Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single-Dose, Crossover Study in Healthy Adults
    Maes, Andrea
    DePetrillo, Paolo
    Siddiqui, Shahid
    Reisner, Colin
    Dorinsky, Paul
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (02): : 223 - 233
  • [38] A PHASE 1 SINGLE ASCENDING DOSE (SAD) STUDY OF FOOD EFFECTS AND DRUG-DRUG INTERACTION (DDI) EFFECTS OF PH-MODIFYING AGENTS ON INCB099318 PHARMACOKINETICS (PK), A PROGRAMMED DEATH-LIGAND 1 (PD-L1) INHIBITOR, IN HEALTHY PARTICIPANTS
    Gong, X.
    Xun, Z.
    Leonetti-Whalen, C.
    Wang, P.
    Chen, X.
    Punwani, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S78 - S78
  • [39] Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Dual GLP-1/GIP Receptor Agonist (HRS9531) in Healthy Subjects-A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose (SAD and MAD) Study
    He, Kun
    Wei, Fang
    Chen, Hong
    Zhang, Yanyan
    Sheng, Zhen
    Wen, Qing
    DIABETES, 2023, 72
  • [40] A RANDOMIZED, SINGLE-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF TAK-272 IN HEALTHY ADULT NON-ELDERLY AND ELDERLY MALE SUBJECTS
    Matsuno, K.
    Tanaka, S.
    Hashimoto, T.
    Nakamichi, H.
    Komura, E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 265 - +
12345